Citigroup’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1
| Closed | -$1 | – | 6481 |
|
|
2025
Q4 | $1 | Sell |
1
-3,527
| -100% | -$7.84K | ﹤0.01% | 6000 |
|
|
2025
Q3 | $6.53K | Buy |
3,528
+3,468
| +5,780% | +$5.65K | ﹤0.01% | 5150 |
|
|
2025
Q2 | $89 | Buy |
+60
| New | +$96 | ﹤0.01% | 5520 |
|
|
2022
Q3 | – | Sell |
-5
| Closed | – | – | 6398 |
|
|
2022
Q2 | $0 | Buy |
+5
| New | +$169 | ﹤0.01% | 6740 |
|
|
2020
Q1 | – | Sell |
-40
| Closed | -$6K | – | 7798 |
|
|
2019
Q4 | $6K | Buy |
+40
| New | +$7.47K | ﹤0.01% | 7363 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7843 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7875 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7841 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7859 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7886 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7763 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7695 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7673 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7165 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7218 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7116 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7138 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6884 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$56.2K | – | 6691 |
|
|
2016
Q1 | $73K | Sell |
2
-1
| -33% | -$31.7K | ﹤0.01% | 5888 |
|
|
2015
Q4 | $134K | Hold |
3
| – | – | ﹤0.01% | 5098 |
|
|
2015
Q3 | $201K | Buy |
3
+1
| +50% | +$107K | ﹤0.01% | 4486 |
|
|
2015
Q2 | $324K | Hold |
2
| – | – | ﹤0.01% | 4074 |
|
|
2015
Q1 | $326K | Hold |
2
| – | – | ﹤0.01% | 4118 |
|
|
2014
Q4 | $348K | Hold |
2
| – | – | ﹤0.01% | 4219 |
|
|
2014
Q3 | $450K | Buy |
2
+1
| +100% | +$285K | ﹤0.01% | 3613 |
|
|
2014
Q2 | $454K | Hold |
1
| – | – | ﹤0.01% | 3527 |
|
|
2014
Q1 | $273K | Buy |
+1
| New | +$602K | ﹤0.01% | 4035 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4855 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4518 |
|
Other funds holding TRAW
IC
O
SCM
DIG
BFM
ACM
PWM
VCM
Citigroup's TRAW Position: Q1 2026 in Review
Citigroup sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 1 share — an estimated $1 sold.
Citigroup first reported a position in TRAW in Q1 2014 and held it in 14 quarters. The position peaked at $454K in Q2 2014. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.
- Citigroup reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 1 Traws Pharma share in Q1 2026, an estimated $1.
- Citigroup first reported a position in Traws Pharma in Q1 2014 and held it in 14 quarters.
- Citigroup's Traws Pharma position peaked at $454K in Q2 2014.
- 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.